Abstract:Tumor hypoxia has been associated with cancer progression, angiogenesis, and metastasis via modifications in the release and cargo composition of extracellular vesicles secreted by tumor cells. Indeed, hypoxic extracellular vesicles are known to trigger a variety of angiogenic responses via different mechanisms. We recently showed that hypoxia promotes endosomal signaling in tumor cells via HIF-1α-dependent induction of the guanine exchange factor ALS2, which activates Rab5, leading to downstream events involved in cell migration and invasion. Since Rab5-dependent signaling is required for endothelial cell migration and angiogenesis, we explored the possibility that hypoxia promotes the release of small extracellular vesicles containing ALS2, which in turn activate Rab5 in recipient endothelial cells leading to pro-angiogenic properties. In doing so, we found that hypoxia promoted ALS2 expression and incorporation as cargo within small extracellular vesicles, leading to subsequent transfer to recipient endothelial cells, promoting cell migration, tube formation and downstream Rab5 activation. Consequently, ALS2-containing small extracellular vesicles increased early endosome size and number in recipient endothelial cells, which was followed by subsequent sequestration of components of the β-catenin destruction complex within endosomal compartments, leading to stabilization and nuclear localization of β-catenin. These events converged in the expression of β-catenin target genes involved in angiogenesis. Knockdown of ALS2 in donor-tumor cells, which precluded its incorporation into small extracellular vesicles, prevented Rab5-downstream events and endothelial cell responses, which depended on Rab5 activity and guanine exchange factor activity of ALS2. These findings indicate that vesicular ALS2, secreted in hypoxia, promotes endothelial cell events leading to angiogenesis. Finally, these events might explain how tumor angiogenesis proceeds in hypoxic conditions.

What problem does this paper attempt to address?

### Problems the Paper Attempts to Solve This paper aims to explore how tumor-derived small extracellular vesicles (sEVs) promote endothelial cell migration and tube formation under hypoxic conditions. Specifically, the researchers focus on the impact of these vesicles on endothelial cell function through the ALS2/Rab5/β-catenin signaling pathway. ### Background Information 1. **Tumor Hypoxia**: Hypoxic conditions in the tumor microenvironment are common and are associated with tumor progression, angiogenesis, and metastasis. 2. **Role of Extracellular Vesicles**: Extracellular vesicles released under hypoxic conditions can trigger various pro-angiogenic responses, but the specific mechanisms are not fully understood. 3. **Role of ALS2 and Rab5**: Previous studies have shown that hypoxia induces the expression of ALS2 in a HIF-1α dependent manner, activating Rab5, thereby promoting cell migration and invasion. Rab5 also plays a crucial role in endothelial cell migration and angiogenesis. ### Research Objectives 1. **Explore the Role of sEVs under Hypoxic Conditions**: Investigate whether sEVs released by tumor cells under hypoxic conditions contain ALS2 and how these sEVs affect the function of recipient endothelial cells. 2. **Reveal the Mechanism of ALS2**: Verify whether ALS2 promotes endothelial cell migration and tube formation by activating Rab5 and further explore its impact on the β-catenin signaling pathway. ### Main Findings 1. **Hypoxic sEVs Promote Endothelial Cell Migration and Tube Formation**: Experimental results show that sEVs released under hypoxic conditions significantly promote endothelial cell migration and tube formation, whereas sEVs under normoxic conditions do not have this effect. 2. **Activation of β-catenin Signaling Pathway**: In endothelial cells treated with hypoxic sEVs, nuclear localization and transcriptional activity of β-catenin significantly increased, which is associated with the increased expression of β-catenin target genes MMP2 and VEGF-A. 3. **Role of ALS2**: The study found that under hypoxic conditions, the content of ALS2 in sEVs increased, and these sEVs activated Rab5 in recipient endothelial cells by delivering ALS2, thereby promoting the activation of the β-catenin signaling pathway. 4. **Role of Rab5**: Activation of Rab5 is crucial for hypoxic sEV-induced endothelial cell migration and tube formation. Knocking down ALS2 or using a Rab5 activity inhibitor can block these effects. ### Conclusion This study reveals that sEVs released by tumor cells under hypoxic conditions promote endothelial cell migration and tube formation by delivering ALS2 to recipient endothelial cells, activating the Rab5 and β-catenin signaling pathways. This mechanism helps to understand the regulation of angiogenesis under tumor hypoxia and provides new insights for the treatment of tumor progression.

Tumor-derived hypoxic small extracellular vesicles promote endothelial cell migration and tube formation via ALS2/Rab5/β-catenin signaling

Hypoxia stabilizes microtubule networks and decreases tumor cell chemosensitivity to anticancer drugs through Egr-1.

Altered Regulation of HIF-1α in Naive- and Drug-Resistant EGFR-Mutant NSCLC: Implications for a Vascular Endothelial Growth Factor-Dependent Phenotype.

Hypoxia-Inducible Factors And Rab22a Mediate Formation Of Microvesicles That Stimulate Breast Cancer Invasion And Metastasis

Angiogenesis is promoted by hypoxic cervical carcinoma-derived extracellular vesicles depending on the endothelial cell environment

Hypoxia regulates small extracellular vesicle biogenesis and cargo sorting through HIF-1α/HRS signaling pathway in head and neck squamous cell carcinoma

Targeted Identification of Sialoglycoproteins in Hypoxic Endothelial Cells and Validation in Zebrafish Reveal Roles for Proteins in Angiogenesis

Therapeutic Efficacy of ECs Foxp1 Targeting Hif1α-Hk2 Α-Hk2 Glycolysis Signal to Restrict Angiogenesis

Hypoxic Exosomes Facilitate Angiogenesis and Metastasis in Esophageal Squamous Cell Carcinoma Through Altering the Phenotype and Transcriptome of Endothelial Cells

Cancer EV stimulate endothelial glycolysis to fuel protein synthesis via mTOR and AMPKα activation

Targeting hypoxia signaling pathways in angiogenesis

Tumor-derived apoptotic extracellular vesicle-mediated intercellular communication promotes metastasis and stemness of lung adenocarcinoma

miR-210-3p enriched extracellular vesicles from hypoxic neuroblastoma cells stimulate migration and invasion of target cells

HSP90/IKK‐rich small extracellular vesicles activate pro‐angiogenic melanoma‐associated fibroblasts via the NF‐κB/CXCL1 axis

EPAS1 promote tumor progression by interacting with Wnt/β-catenin signaling in pancreatic cancer

Exosomes Carrying ALDOA and ALDH3A1 from Irradiated Lung Cancer Cells Enhance Migration and Invasion of Recipients by Accelerating Glycolysis.

Effects of Hypoxia and Radiation-Induced Exosomes on Migration of Lung Cancer Cells and Angiogenesis of Umbilical Vein Endothelial Cells

Hypoxic Cancer-Secreted Exosomal Mir-182-5p Promotes Glioblastoma Angiogenesis by Targeting Kruppel-Like Factor 2 and 4

Tumor Perivascular Cell-Derived Extracellular Vesicles Promote Angiogenesis Via the Gas6/Axl Pathway.

Tumor Hypoxia Regulates Immune Escape/Invasion: Influence on Angiogenesis and Potential Impact of Hypoxic Biomarkers on Cancer Therapies

HIF1α Counteracts TGFβ1-Driven TSP1 Expression in Endothelial Cells to Stimulate Angiogenesis in the Hypoxic Tumor Microenvironment